Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Pharmaxis Ltd ( (AU:SNT) ) just unveiled an update.
Pharmaxis Ltd has released its annual report for the year ending June 30, 2025. The report includes comprehensive financial statements and disclosures, providing insights into the company’s financial health and operational performance. This release is crucial for stakeholders to assess the company’s market position and future prospects.
The most recent analyst rating on (AU:SNT) stock is a Buy with a A$0.06 price target. To see the full list of analyst forecasts on Pharmaxis Ltd stock, see the AU:SNT Stock Forecast page.
More about Pharmaxis Ltd
Average Trading Volume: 7,328,631
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$42.32M
For an in-depth examination of SNT stock, go to TipRanks’ Overview page.